IR UpFront
SIR Foundation needs your help finding the next Leader in Innovation!
SIR Foundation’s Leader in Innovation Award recognizes and promotes innovation within interventional radiology, continuing IR’s historical innovative development that has
revolutionized medicine over the last 50+ years.
Do you know an individual who has conceptualized and implemented an idea that has had an advantageous impact on the practice of IR? If so, nominate them by June 1 for the 2025 SIR Foundation Leader in Innovation Award.
The innovation can be a device, technique, approach, clinical practice model or anything having a significant improvement upon the quality of patient care or economics of interventional practice.
tfaforms.com/5106973
SIR partners with congresswoman to improve blood clot education and prevention
The 2024 IR Residency Match points to a bright future for IR
Congratulations to our trainees, program coordinators and program directors on another successful Match!
On March 15, 187 residents matched into integrated IR residency programs, filling 98.4% of the 190 available integrated residency positions, which represents a 6.7% increase in available positions. This was the ninth time IR has participated in the NRMP Main Residency Match. Since 2019, Integrated IR residency match rate has ranged from 94.9% to 100%, indicating that IR remains one of the most competitive residencies in medicine.
SIR is asking Congress to support the “Charles Rochester Blood Clot Prevention and Treatment Act” (H.R. 5699), introduced by Rep. Lisa Blunt Rochester, D-Del., in memory of her late husband, who passed away due to a blood clot at the age of 52. The bill directs the Centers for Disease Control and Prevention to launch a national campaign to increase public awareness of blood clot signs and symptoms and would establish an advisory committee to help streamline effective diagnosis, treatment, and prevention of blood clots and pulmonary embolisms.
SIR is also partnering with Rep. Blunt Rochester to increase awareness and understanding of the important role IR can play in the treatment of blood clots. Recently, SIR contributed to the Blood Clot Awareness, Action and Advocacy Toolkit distributed by Rep. Blunt Rochester. The toolkit was shared during a livestream, which featured SIR member Assaf Graif, MD, who discussed the importance of blood clot awareness that can lead to early treatment of blood clots. We encourage you to download and share the toolkit with your patients and colleagues.
10 IRQ | SPRING 2024
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40
